JPMORGAN CHASE & CO - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 50 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$102,064
+3611.4%
69,907
+5720.7%
0.00%
Q2 2023$2,750
+175.0%
1,2010.0%0.00%
Q1 2023$1,000
+99900.0%
1,2010.0%0.00%
Q4 2022$1
-100.0%
1,201
-56.9%
0.00%
Q3 2022$2,0000.0%2,786
+41.6%
0.00%
Q2 2022$2,000
-77.8%
1,968
-64.2%
0.00%
Q1 2022$9,000
-10.0%
5,499
+34.0%
0.00%
Q4 2021$10,000
-95.6%
4,103
-93.8%
0.00%
Q2 2019$226,000
-66.4%
66,687
-60.1%
0.00%
Q1 2019$673,000
-20.0%
167,121
-27.1%
0.00%
Q4 2018$841,000
-16.7%
229,292
+95.1%
0.00%
Q3 2018$1,009,000
-19.7%
117,513
+2.6%
0.00%
Q2 2018$1,257,000
-50.0%
114,516
-47.5%
0.00%
-100.0%
Q1 2018$2,516,000
-1.1%
218,197
-11.1%
0.00%0.0%
Q4 2017$2,544,000
-50.2%
245,461
-22.4%
0.00%0.0%
Q3 2017$5,106,000
+26.9%
316,200
-4.9%
0.00%0.0%
Q2 2017$4,025,000
+25.8%
332,634
+116.0%
0.00%0.0%
Q1 2017$3,199,000
+24.2%
153,976
-14.5%
0.00%0.0%
Q4 2016$2,576,000
-5.0%
180,099
+9.2%
0.00%0.0%
Q3 2016$2,713,000
+8.7%
164,900
-5.8%
0.00%0.0%
Q2 2016$2,497,000175,1000.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders